Tri Locum Partners LP - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 135 filers reported holding XENON PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 10.04 and the average weighting 0.4%.

Quarter-by-quarter ownership
Tri Locum Partners LP ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$5,867,151
+529.2%
171,755
+609.1%
1.88%
+440.6%
Q2 2023$932,509
-88.2%
24,221
-89.1%
0.35%
-85.6%
Q1 2023$7,935,717
+115.6%
221,730
+137.5%
2.42%
+62.3%
Q4 2022$3,681,000
-24.1%
93,364
-30.5%
1.49%
+11.9%
Q3 2022$4,849,000
-4.2%
134,331
-19.3%
1.33%
-35.8%
Q2 2022$5,062,000
+547.3%
166,399
+564.5%
2.07%
+573.1%
Q4 2021$782,000
-80.6%
25,043
-90.5%
0.31%
-80.8%
Q3 2021$4,036,000264,1341.60%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Ghost Tree Capital, LLC 790,000$12,071,0003.53%
GREAT POINT PARTNERS LLC 700,000$10,696,0002.49%
COMMODORE CAPITAL LP 579,432$8,854,0002.33%
ACUTA CAPITAL PARTNERS, LLC 417,409$6,378,0002.25%
DAFNA Capital Management LLC 406,535$6,212,0001.65%
Tri Locum Partners LP 264,134$4,036,0001.60%
Parkman Healthcare Partners LLC 311,207$4,755,0001.20%
Ghost Tree Capital, LLC 250,000$3,820,0001.12%
Nan Fung Group Holdings Ltd 197,880$3,024,0000.97%
BVF INC/IL 1,571,778$24,017,0000.94%
View complete list of XENON PHARMACEUTICALS INC shareholders